Create Alert
Watchlist

Ipca Laboratories

₹1,444.00
+5.80 (0.40%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,427.00
Prev. Close
1,438.20
Volume
1,74,552
Total traded value
25.21 Cr
Upper Circuit
1,732.80
Lower Circuit
1,155.20

Fundamentals

Market Cap₹36,631Cr
ROE13.33%
P/E Ratio(TTM)42.91
EPS(TTM)33.65
P/B Ratio4.93
Dividend Yield0.28%
Industry P/E33.19
Book Value292.74
Debt to Equity0.17
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ipca Laboratories

Ipca Laboratories Limited, established in 1949, is a fully integrated Indian pharmaceutical company that develops, manufactures, and markets a wide range of medicines. The company's primary business is the manufacturing and marketing of pharmaceuticals, producing both active ingredients (APIs) and over 350 ready-to-use formulations. In the Indian market, the company operates through 22 marketing divisions and is ranked as the 16th largest in the domestic formulations business. It has a vast global presence, with its products being exported to more than 100 countries across the world. Ipca drives innovation through its R&D centers, focusing on new processes for APIs and developing modern drug delivery systems. As part of its sustainability initiatives, the company has been investing in renewable energy projects such as wind and solar power generation for its own use.;
Parent OrganisationIpca Laboratories
Managing DirectorPranay Godha
NSE SymbolIPCALAB

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
44.72%
Mutual Funds
30.04%
Foreign Institutions
10.43%
Retail And Others
8.07%
Other Domestic Institutions
6.73%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
40.73
Cipla
NA
(0.00%)
22.47
Dr Reddy's Laboratories
NA
(0.00%)
18.11
Zydus Lifesciences
NA
(0.00%)
18.50